Recognition of distinct cross-reactive virus-specific CD8+ T cells reveals a unique TCR signature in a clinical setting

Journal of Immunology

Volumn 192, Issue 11, 2014, Pages 5039-5049

  Nguyen, Thi H O ^a,b   Rowntree, Louise C ^a,b   Pellicci, Daniel G ^c   Bird, Nicola L ^c   Handel, Andreas ^d   Kjer Nielsen, Lars ^c   Kedzierska, Katherine ^c   Kotsimbos, Tom C ^a,b   Mifsud, Nicole A ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA A ANTIGEN; HLA B27 ANTIGEN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANTIGEN RECOGNITION; ARTICLE; CD8+ T LYMPHOCYTE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RELEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GRAFT RECIPIENT; HUMAN; HUMAN CELL; IMMUNOMODULATION; LUNG TRANSPLANTATION; MULTIPLEX POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REACTIVATION;

ALLOGRAFTS; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HLA-A2 ANTIGEN; HUMANS; INTERFERON-GAMMA; LUNG TRANSPLANTATION; MALE; MONITORING, PHYSIOLOGIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 84901277199     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303147     Document Type: Article

References (60)

1. Christie, J. D., L. B. Edwards, A. Y. Kucheryavaya, C. Benden, A. I. Dipchand, F. Dobbels, R. Kirk, A. O. Rahmel, J. Stehlik, M. I. Hertz; International Society of Heart and Lung Transplantation. 2012. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant. 31: 1073-1086.
2. Snyder, L. D., C. A. Finlen-Copeland, W. J. Turbyfill, D. Howell, D. A. Willner, and S. M. Palmer. 2010. Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation. Am. J. Respir. Crit. Care Med. 181: 1391-1396.
3. Paraskeva, M., M. Bailey, B. J. Levvey, A. P. Griffiths, T. C. Kotsimbos, T. P. Williams, G. Snell, and G. Westall. 2011. Cytomegalovirus replication within the lung allograft is associated with bronchiolitis obliterans syndrome. Am. J. Transplant. 11: 2190-2196.
4. Davis, J. E., M. A. Sherritt, M. Bharadwaj, L. E. Morrison, S. L. Elliott, L. M. Kear, J. Maddicks-Law, T. Kotsimbos, D. Gill, M. Malouf, et al. 2004. Determining virological, serological and immunological parameters of EBV infection in the development of PTLD. Int. Immunol. 16: 983-989.
5. Westall, G. P., A. Michaelides, T. J. Williams, G. I. Snell, and T. C. Kotsimbos. 2003. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation. Transplantation 75: 2064-2068.
6. Wong, J. Y., B. Tait, B. Levvey, A. Griffiths, D. S. Esmore, G. I. Snell, T. J. Williams, and T. C. Kotsimbos. 2004. Epstein-Barr virus primary mismatching and HLA matching: key risk factors for post lung transplant lymphoproliferative disease. Transplantation 78: 205-210.
7. Wreghitt, T. 1989. Cytomegalovirus infections in heart and heart-lung transplant recipients. J Antimicrob Chemother 23(Suppl. E): 49-60.
8. Hislop, A. D., N. E. Annels, N. H. Gudgeon, A. M. Leese, and A. B. Rickinson. 2002. Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection. J. Exp. Med. 195: 893-905.
9. Levitsky, V., P. O. de Campos-Lima, T. Frisan, and M. G. Masucci. 1998. The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time. J. Immunol. 161: 594-601.
10. Maecker, H. T., and V. C. Maino. 2004. Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry. Hum. Immunol. 65: 493-499.
11. Benninger-Döring, G., S. Pepperl, L. Deml, S. Modrow, H. Wolf, and W. Jilg. 1999. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers. Virology 264: 289-297.
12. Amir, A. L., L. J. D'Orsogna, D. L. Roelen, M. M. van Loenen, R. S. Hagedoorn, R. de Boer, M. A. van der Hoorn, M. G. Kester, I. I. Doxiadis, II, J. H. Falkenburg, et al. 2010. Allo-HLA reactivity of virus-specific memory T cells is common. Blood 115: 3146-3157.
13. Burrows, S. R., R. Khanna, J. M. Burrows, and D. J. Moss. 1994. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J. Exp. Med. 179: 1155-1161.
14. Burrows, S. R., S. L. Silins, S. M. Cross, C. A. Peh, M. Rischmueller, J. M. Burrows, S. L. Elliott, and J. McCluskey. 1997. Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire. Eur. J. Immunol. 27: 178-182.
15. Elkington, R., S. Walker, T. Crough, M. Menzies, J. Tellam, M. Bharadwaj, and R. Khanna. 2003. Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers. J. Virol. 77: 5226-5240.
16. Gamadia, L. E., E. B. Remmerswaal, S. Surachno, N. M. Lardy, P. M. Wertheimvan Dillen, R. A. van Lier, and I. J. ten Berge. 2004. Cross-reactivity of cytomegalovirus-specific CD8+ T cells to allo-major histocompatibility complex class I molecules. Transplantation 77: 1879-1885.
17. Koelle, D. M., H. B. Chen, C. M. McClurkan, and E. W. Petersdorf. 2002. Herpes simplex virus type 2-specific CD8 cytotoxic T lymphocyte crossreactivity against prevalent HLA class I alleles. Blood 99: 3844-3847.
18. Rist, M., C. Smith, M. J. Bell, S. R. Burrows, and R. Khanna. 2009. Crossrecognition of HLA DR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-/nonself-recognition. Blood 114: 2244-2253.
19. Nguyen, T. H., G. P. Westall, T. E. Bull, A. C. Meehan, N. A. Mifsud, and T. C. Kotsimbos. 2013. Cross-reactive anti-viral T cells increase prior to an episode of viral reactivation post human lung transplantation. PLoS ONE 8: e56042.
20. Mifsud, N. A., T. H. Nguyen, B. D. Tait, and T. C. Kotsimbos. 2010. Quantitative and functional diversity of cross-reactive EBV-specific CD8+ T cells in a longitudinal study cohort of lung transplant recipients. Transplantation 90: 1439-1449.
21. Melenhorst, J. J., A. M. Leen, C. M. Bollard, M. F. Quigley, D. A. Price, C. M. Rooney, M. K. Brenner, A. J. Barrett, and H. E. Heslop. 2010. Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects. Blood 116: 4700-4702.
22. Nguyen, T. H., L. C. Sullivan, T. C. Kotsimbos, A. P. Schwarer, and N. A. Mifsud. 2010. Cross-presentation of HCMV chimeric protein enables generation and measurement of polyclonal T cells. Immunol. Cell Biol. 88: 676-684.
23. Mifsud, N. A., A. W. Purcell, W. Chen, R. Holdsworth, B. D. Tait, and J. McCluskey. 2008. Immunodominance hierarchies and gender bias in direct T(CD8)-cell alloreactivity. Am. J. Transplant. 8: 121-132.
24. Holst, J., A. L. Szymczak-Workman, K. M. Vignali, A. R. Burton, C. J.Workman, and D. A. Vignali. 2006. Generation of T-cell receptor retrogenic mice. Nat. Protoc. 1: 406-417.
25. Szymczak, A. L., C. J. Workman, Y. Wang, K. M. Vignali, S. Dilioglou, E. F. Vanin, and D. A. Vignali. 2004. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat. Biotechnol. 22: 589-594.
26. Macdonald, W. A., A. W. Purcell, N. A. Mifsud, L. K. Ely, D. S. Williams, L. Chang, J. J. Gorman, C. S. Clements, L. Kjer-Nielsen, D. M. Koelle, et al. 2003. A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J. Exp. Med. 198: 679-691.
27. Macdonald, W. A., Z. Chen, S. Gras, J. K. Archbold, F. E. Tynan, C. S. Clements, M. Bharadwaj, L. Kjer-Nielsen, P. M. Saunders, M. C. Wilce, et al. 2009. T cell allorecognition via molecular mimicry. Immunity 31: 897-908.
28. Wang, G. C., P. Dash, J. A. McCullers, P. C. Doherty, and P. G. Thomas. 2012. T cell receptor alphabeta diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection. Sci. Transl. Med. 4: 128ra142.
29. Brochet, X., M. P. Lefranc, and V. Giudicelli. 2008. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36(Web Server issue): W503-W508.
30. Folch, G., D. Scaviner, V. Contet, and M. P. Lefranc. 2000. Protein displays of the human T cell receptor alpha, beta, gamma and delta variable and joining regions. Exp. Clin. Immunogenet. 17: 205-215.
31. Reantragoon, R., L. Kjer-Nielsen, O. Patel, Z. Chen, P. T. Illing, M. Bhati, L. Kostenko, M. Bharadwaj, B. Meehan, T. H. Hansen, et al. 2012. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor. J. Exp. Med. 209: 761-774.
32. Agresti, A. 2002. Categorical data analysis. Wiley, New York.
33. Team, R. C. 2013. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
34. Gonzalez-Galarza, F. F., S. Christmas, D. Middleton, and A. R. Jones. 2011. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res. 39(Database issue): D913-D919.
35. Day, E. K., A. J. Carmichael, I. J. ten Berge, E. C. Waller, J. G. Sissons, and M. R. Wills. 2007. Rapid CD8+ T cell repertoire focusing and selection of highaffinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus. J. Immunol. 179: 3203-3213.
36. Dong, L., P. Li, T. Oenema, C. L. McClurkan, and D. M. Koelle. 2010. Public TCR use by herpes simplex virus-2-specific human CD8 CTLs. J. Immunol. 184: 3063-3071.
37. Khan, N., N. Shariff, M. Cobbold, R. Bruton, J. A. Ainsworth, A. J. Sinclair, L. Nayak, and P. A. Moss. 2002. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J. Immunol. 169: 1984-1992.
38. Price, D. A., J. M. Brenchley, L. E. Ruff, M. R. Betts, B. J. Hill, M. Roederer, R. A. Koup, S. A. Migueles, E. Gostick, L. Wooldridge, et al. 2005. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J. Exp. Med. 202: 1349-1361.
39. Trautmann, L., M. Rimbert, K. Echasserieau, X. Saulquin, B. Neveu, J. Dechanet, V. Cerundolo, and M. Bonneville. 2005. Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses. J. Immunol. 175: 6123-6132.
40. Weekes, M. P., M. R. Wills, K. Mynard, A. J. Carmichael, and J. G. Sissons. 1999. The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J. Virol. 73: 2099-2108.
41. Peggs, K., S. Verfuerth, A. Pizzey, J. Ainsworth, P. Moss, and S. Mackinnon. 2002. Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. Blood 99: 213-223.
42. Venturi, V., H. Y. Chin, T. E. Asher, K. Ladell, P. Scheinberg, E. Bornstein, D. van Bockel, A. D. Kelleher, D. C. Douek, D. A. Price, and M. P. Davenport. 2008. TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV. J. Immunol. 181: 7853-7862.
43. Wills, M. R., A. J. Carmichael, K. Mynard, X. Jin, M. P. Weekes, B. Plachter, and J. G. Sissons. 1996. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J. Virol. 70: 7569-7579.
44. Gras, S., X. Saulquin, J. B. Reiser, E. Debeaupuis, K. Echasserieau, A. Kissenpfennig, F. Legoux, A. Chouquet, M. Le Gorrec, P. Machillot, et al. 2009. Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope. J. Immunol. 183: 430-437.
45. Morice, A., B. Charreau, B. Neveu, S. Brouard, J. P. Soulillou, M. Bonneville, E. Houssaint, and N. Degauque. 2010. Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules. PLoS ONE 5: e12120.
46. Kjer-Nielsen, L., O. Patel, A. J. Corbett, J. Le Nours, B. Meehan, L. Liu, M. Bhati, Z. Chen, L. Kostenko, R. Reantragoon, et al. 2012. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491: 717-723.
47. Miconnet, I., A. Marrau, A. Farina, P. Taffé, S. Vigano, A. Harari, and G. Pantaleo. 2011. Large TCR diversity of virus-specific CD8 T cells provides the mechanistic basis for massive TCR renewal after antigen exposure. J. Immunol. 186: 7039-7049.
48. Solache, A., C. L. Morgan, A. I. Dodi, C. Morte, I. Scott, C. Baboonian, B. Zal, J. Goldman, J. E. Grundy, and J. A. Madrigal. 1999. Identification of three HLAA* 0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus. J. Immunol. 163: 5512-5518.
49. Iancu, E. M., P. Corthesy, P. Baumgaertner, E. Devevre, V. Voelter, P. Romero, D. E. Speiser, and N. Rufer. 2009. Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time. J. Immunol. 183: 319-331.
50. Blanco-Gelaz, M. A., B. Suárez-Alvarez, R. Díaz-Peña, and C. López-Larrea. 2009. HLA-B27 polymorphism at position 116 critically influences the association with TAP/tapasin, intracellular trafficking and conformational homodimers formation. Mol. Immunol. 46: 1304-1311.
51. Fiorillo, M. T., C. Ruckert, M. Hulsmeyer, R. Sorrentino, W. Saenger, A. Ziegler, and B. Uchanska-Ziegler. 2005. Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes. J. Biol. Chem. 280: 2962-2971.
52. Fiorillo, M. T., G. Greco, M. Maragno, I. Potolicchio, A. Monizio, M. L. Dupuis, and R. Sorrentino. 1998. The naturally occurring polymorphism Asp116 His116, differentiating the ankylosing spondylitis-associated HLAB* 2705 from the non-associated HLA-B*2709 subtype, influences peptidespecific CD8 T cell recognition. Eur. J. Immunol. 28: 2508-2516.
53. Fiorillo, M. T., M. Maragno, R. Butler, M. L. Dupuis, and R. Sorrentino. 2000. CD8(+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. J. Clin. Invest. 106: 47-53.
54. Fiorillo, M. T., L. Meadows, M. D'Amato, J. Shabanowitz, D. F. Hunt, E. Appella, and R. Sorrentino. 1997. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLAB27 subtypes. Eur. J. Immunol. 27: 368-373.
55. López-Larrea, C., K. Sujirachato, N. K. Mehra, P. Chiewsilp, D. Isarangkura, U. Kanga, O. Dominguez, E. Coto, M. Penã, F. Setién, et al. 1995. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 45: 169-176.
56. Zernich, D., A. W. Purcell, W. A. Macdonald, L. Kjer-Nielsen, L. K. Ely, N. Laham, T. Crockford, N. A. Mifsud, M. Bharadwaj, L. Chang, et al. 2004. Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion. J. Exp. Med. 200: 13-24.
57. D'Orsogna, L. J., D. L. Roelen, E. M. van der Meer-Prins, P. van der Pol, M. E. Franke-van Dijk, M. Eikmans, J. Anholts, J. Rossjohn, J. McCluskey, A. Mulder, et al. 2011. Tissue specificity of cross-reactive allogeneic responses by EBV EBNA3A-specific memory T cells. Transplantation 91: 494-500.
58. Estenne, M., and M. I. Hertz. 2002. Bronchiolitis obliterans after human lung transplantation. Am. J. Respir. Crit. Care Med. 166: 440-444.
59. Jaraquemada, D., B. Galocha, P. Aparicio, S. Rojo, V. Calvo, and J. A. López de Castro. 1988. Modulation on immunogenicity by HLA-B27 subtype polymorphism. Eur. J. Immunol. 18: 1945-1950.
60. Yang, T., Z. Duan, S. Wu, S. Liu, Z. Zeng, G. Li, S. Wang, D. Fan, D. Ye, S. Xu, et al. 2014. Association of HLA-B27 genetic polymorphisms with ankylosing spondylitis susceptibility worldwide: a meta-analysis. Mod. Rheumatol. 24: 150-161.